Which has higher valuation & earnings, ENGNW or AIMDW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio enGene N/A N/A N/A N/A N/A Ainos $18.11K N/A N/A N/A N/A

Is ENGNW or AIMDW more profitable?

Company Net Margins Return on Equity Return on Assets enGene N/A N/A N/A Ainos N/A N/A N/A

Which has better valuation & earnings, ALVOW or ENGNW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $559.42M N/A N/A N/A N/A enGene N/A N/A N/A N/A N/A

Is ALVOW or ENGNW more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A enGene N/A N/A N/A

Does the media prefer ALVOW or ENGNW?

In the previous week, enGene had 5 more articles in the media than Alvotech. MarketBeat recorded 7 mentions for enGene and 2 mentions for Alvotech. Alvotech's average media sentiment score of 0.50 beat enGene's score of 0.24 indicating that Alvotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alvotech 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive enGene 0 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings and valuation, ARAV or ENGNW?

enGene has lower revenue, but higher earnings than Aravive. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aravive $6.99M 0.42 -$66.21M -$0.90 N/A enGene N/A N/A N/A N/A N/A

Is ARAV or ENGNW more profitable?

Company Net Margins Return on Equity Return on Assets Aravive N/A N/A N/A enGene N/A N/A N/A

Which has preferable earnings and valuation, ACABW or ENGNW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A enGene N/A N/A N/A N/A N/A

Is ACABW or ENGNW more profitable?

Company Net Margins Return on Equity Return on Assets Atlantic Coastal Acquisition Corp. II N/A N/A N/A enGene N/A N/A N/A

Which has higher valuation & earnings, ENGNW or BFRIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio enGene N/A N/A N/A N/A N/A Biofrontera $43.20M N/A N/A N/A N/A

Is ENGNW or BFRIW more profitable?

Company Net Margins Return on Equity Return on Assets enGene N/A N/A N/A Biofrontera N/A N/A N/A

enGene (ENGNW) Competitors

$0.29 +0.00 (+0.03%)

As of 07/2/2026 10:00 AM Eastern

Compare

ENGNW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy enGene stock or one of its competitors? MarketBeat compares enGene with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with enGene include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does enGene compare to Ainos?

enGene (NASDAQ:ENGNW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enGene	N/A	N/A	N/A	N/A	N/A
Ainos	$18.11K	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
enGene	N/A	N/A	N/A
Ainos	N/A	N/A	N/A

In the previous week, enGene had 7 more articles in the media than Ainos. MarketBeat recorded 7 mentions for enGene and 0 mentions for Ainos. enGene's average media sentiment score of 0.24 beat Ainos' score of 0.00 indicating that enGene is being referred to more favorably in the media.

Company	Overall Sentiment
enGene	Neutral
Ainos	Neutral

Summary

enGene beats Ainos on 2 of the 3 factors compared between the two stocks.

How does enGene compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and enGene (NASDAQ:ENGNW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$559.42M	N/A	N/A	N/A	N/A
enGene	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
enGene	N/A	N/A	N/A

In the previous week, enGene had 5 more articles in the media than Alvotech. MarketBeat recorded 7 mentions for enGene and 2 mentions for Alvotech. Alvotech's average media sentiment score of 0.50 beat enGene's score of 0.24 indicating that Alvotech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alvotech	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
enGene	0 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Alvotech beats enGene on 2 of the 3 factors compared between the two stocks.

How does enGene compare to Aravive?

Aravive (NASDAQ:ARAV) and enGene (NASDAQ:ENGNW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

In the previous week, enGene had 7 more articles in the media than Aravive. MarketBeat recorded 7 mentions for enGene and 0 mentions for Aravive. enGene's average media sentiment score of 0.24 beat Aravive's score of 0.00 indicating that enGene is being referred to more favorably in the news media.

Company	Overall Sentiment
Aravive	Neutral
enGene	Neutral

enGene has lower revenue, but higher earnings than Aravive.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aravive	$6.99M	0.42	-$66.21M	-$0.90	N/A
enGene	N/A	N/A	N/A	N/A	N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
Aravive	N/A	N/A	N/A
enGene	N/A	N/A	N/A

Summary

Aravive beats enGene on 3 of the 5 factors compared between the two stocks.

How does enGene compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and enGene (NASDAQ:ENGNW) are both pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

Company	Net Margins	Return on Equity	Return on Assets
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A
enGene	N/A	N/A	N/A

In the previous week, enGene had 7 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 7 mentions for enGene and 0 mentions for Atlantic Coastal Acquisition Corp. II. enGene's average media sentiment score of 0.24 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that enGene is being referred to more favorably in the news media.

Company	Overall Sentiment
Atlantic Coastal Acquisition Corp. II	Neutral
enGene	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
enGene	N/A	N/A	N/A	N/A	N/A

Summary

enGene beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does enGene compare to Biofrontera?

enGene (NASDAQ:ENGNW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enGene	N/A	N/A	N/A	N/A	N/A
Biofrontera	$43.20M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
enGene	N/A	N/A	N/A
Biofrontera	N/A	N/A	N/A

In the previous week, enGene had 7 more articles in the media than Biofrontera. MarketBeat recorded 7 mentions for enGene and 0 mentions for Biofrontera. enGene's average media sentiment score of 0.24 beat Biofrontera's score of 0.00 indicating that enGene is being referred to more favorably in the media.

Company	Overall Sentiment
enGene	Neutral
Biofrontera	Neutral

Summary

enGene beats Biofrontera on 2 of the 3 factors compared between the two stocks.

Get enGene News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ENGNW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ENGNW vs. The Competition

Export

Metric	enGene	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$502.88M	$6.97B	$12.40B
Dividend Yield	N/A	3.87%	2.68%	6.63%
P/E Ratio	N/A	3.17	27.78	24.72
Price / Sales	N/A	6,519.46	537.98	98.03
Price / Cash	N/A	13.13	48.59	58.15
Price / Book	N/A	89.20	10.99	6.45
Net Income	N/A	-$96.07M	$3.57B	$336.71M
7 Day Performance	0.35%	0.28%	2.20%	1.37%
1 Month Performance	25.54%	1.63%	4.56%	1.67%
1 Year Performance	-69.51%	67.24%	33.36%	23.99%

enGene Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ENGNW enGene	N/A	$0.29 +0.0%	N/A	-69.5%	$0.00	N/A	N/A	31
AIMDW Ainos	N/A	$0.13 +5.6%	N/A	+14.2%	$0.00	$18.11K	N/A	40	Positive News Short Interest Decrease Gap Up
ALVOW Alvotech	N/A	$0.17 flat	N/A	-90.2%	$0.00	$559.42M	N/A	4	News Coverage
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	N/A	$0.00	N/A	N/A	15

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ENGNW) was last updated on 7/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

enGene (ENGNW) Competitors